Birdwatch Archive

Birdwatch Note Rating

2024-08-14 13:35:20 UTC - NOT_HELPFUL

Rated by Participant: D88F846D0876F5D6A782F707941C8F35B57E8E5C9FB6938ECEDFFD30B60C7B76
Participant Details

Original Note:

The scholarly articles have report "...These results suggest that a third dose of BNT162b2 is safe, improves humoral immunity against SARS-CoV-2, and could be immunologically beneficial for cancer patients on active chemotherapy." : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004706/ A scientific study is needed NOT speculation

All Note Details

Original Tweet

All Information

  • noteId - 1823488630217957579
  • participantId -
  • raterParticipantId - D88F846D0876F5D6A782F707941C8F35B57E8E5C9FB6938ECEDFFD30B60C7B76
  • createdAtMillis - 1723642520906
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1823488630217957579D88F846D0876F5D6A782F707941C8F35B57E8E5C9FB6938ECEDFFD30B60C7B76